Public Profile

Rafarm

Rafarm, officially known as Rafarm S.A., is a prominent player in the pharmaceutical industry, headquartered in Greece (GR). Established in 1975, the company has made significant strides in the development and manufacturing of high-quality generic medicines and active pharmaceutical ingredients (APIs). With a strong operational presence across Europe and beyond, Rafarm is dedicated to enhancing healthcare through innovative solutions. The company’s core offerings include a diverse range of generic pharmaceuticals, which are distinguished by their rigorous quality standards and competitive pricing. Rafarm's commitment to research and development has positioned it as a trusted partner in the healthcare sector, contributing to its reputation for excellence. Over the years, Rafarm has achieved notable milestones, solidifying its market position as a leader in the pharmaceutical landscape.

DitchCarbon Score

How does Rafarm's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

0

Industry Average

Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

6

Industry Benchmark

Rafarm's score of 0 is lower than 99% of the industry. This can give you a sense of how well the company is doing compared to its peers.

1%

Rafarm's reported carbon emissions

Rafarm, headquartered in Greece (GR), currently does not have publicly available carbon emissions data or specific reduction targets. Without concrete figures or commitments, it is challenging to assess their carbon footprint or climate initiatives. However, the absence of emissions data suggests that Rafarm may be in the early stages of developing a comprehensive climate strategy. As the industry increasingly prioritises sustainability, it is essential for Rafarm to establish measurable targets and transparent reporting to align with global climate commitments.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Rafarm's primary industry is Health and social work services (85), which is low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. Rafarm is headquartered in GR, which has a rank of medium, indicating medium grid carbon intensity.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Rafarm is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
Carbon Disclosure Project
The Climate Pledge
UN Global Compact

Other Organizations in Health Services

Rayne

US
Health Services
Updated 10 days ago

Stephens Pipe & Steel

US
Health Services
Updated about 12 hours ago

Haosun Pharmaceutical

CN
Health Services
Updated 8 days ago
CDP

Degasa USA LLC

US
Health Services
Updated 10 days ago

Reig Jofre Group

ES
Health Services
Updated 10 days ago

GE Healthcare Clinical Systems SLU

ES
Health Services
Updated 3 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers